Have a personal or library account? Click to login
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis Cover

Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis

Radiology and Oncology
Volume 57 (2023): Issue 3 (September 2023)
By: Lidija Ljubicic,  Urska Janzic,  Mojca Unk,  Ana Sophie Terglav,  Katja Mohorcic,  Fran Seiwerth,  Lela Bitar,  Sonja Badovinac,  Sanja Plestina,  Marta Korsic,  Suzana Kukulj,  Miroslav Samarzija and  Marko Jakopovic  
Open Access
|Sep 2023
DOI: https://doi.org/10.2478/raon-2023-0040 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 397 - 404
Submitted on: May 15, 2023
|
Accepted on: Jul 16, 2023
|
Published on: Sep 4, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
advanced NSCLC,
antiangiogenic therapy,
docetaxel,
nintedanib,
real-world data
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2023 Lidija Ljubicic, Urska Janzic, Mojca Unk, Ana Sophie Terglav, Katja Mohorcic, Fran Seiwerth, Lela Bitar, Sonja Badovinac, Sanja Plestina, Marta Korsic, Suzana Kukulj, Miroslav Samarzija, Marko Jakopovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 57 (2023): Issue 3 (September 2023)Next article